<div class="article">
	<h3>Technology:
   Cambridge BioScience Corp.</h3>
	<div class="article-info">
		<ul>
			<li>Author: Author Unknown</li>
			<li>Date: 05/02/90</li>
		</ul>
	</div>
	<p class="article-leader">WORCESTER, Mass. -- Cambridge BioScience Corp. said that
the Food and Drug Administration gave it a license for its
Recombigen AIDS antibody detection test.
   Cambridge BioScience said the two-hour test, designed for
high-volume screening at blood banks and laboratories, gives
few false positive readings compared with other tests.</p>
	<div class="article-body"><p></p></div>
</div>
